Company Overview
| Stock Name | 東光化工有限公司 |
|---|---|
| Stock Code | 01702 |
| Company Full Name | 東光化工有限公司 |
| Industry | 原材料 |
| Principal Activities | 主要於中國從事制造及銷售尿素及其他副產品（包括甲醇、液體二氧化碳及液態天然氣）業務。 |
| Listing Date | 2017-07-11 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國河北省東光縣城東工業區 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.dg-chemical.com |
| Share Registrar | |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.06 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 16,960,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 1.6 |
|---|---|
| First Day Open | HK$ 1.0 |
| First Day Change | 50.94% |
| First Day Volume | 50428000.0 |
| First Day Turnover | 68014900.0 |
Use of Proceeds
| Use of Proceeds | 1、約46.9%或約70.0百萬港元將用作采購生產設備及于中國建設新生產設施，以生產大顆粒尿素產品； 2、約35.7%或約53.3百萬港元將用以購買、建設及安裝環保設施； 3、約10.0%或約15.0百萬港元將用以向兩名獨立第三方部分償還兩項有期貸款； 4、約7.4%或約11.1百萬港元將用作一般補充營運資金及其他一般企業用途以改善流動資金狀況。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
KGI CAPITAL ASIA LIMITED CE ADT039
Overall Coordinators (1)
KGI CAPITAL ASIA LIMITED CE ADT039
Joint Bookrunners (2)
KGI CAPITAL ASIA LIMITED CE ADT039
国泰君安证券（香港）有限公司 CE ABY236
Joint Lead Managers (2)
KGI CAPITAL ASIA LIMITED CE ADT039
国泰君安证券（香港）有限公司 CE ABY236
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 王春萌 |
|---|---|
| Company Secretary | 鄭承熙 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Sino-Coal Chemical Holding Group(45.04%);Bloom Ocean Investments Limited(29.04%);國富(香港)控股有限公司(5.01%) |
|---|
